All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| TUYA / Tuya Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ACRV / Acrivon Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| IKNA / Ikena Oncology, Inc.
|
|
|
|
|
|
|
|
| XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NEUE / NeueHealth, Inc.
|
|
|
|
|
|
|
|
| RPHM / Reneo Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
| GERN / Geron Corporation
|
|
|
|
|
|
|
|
| GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
| LXRX / Lexicon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
| SGMT / Sagimet Biosciences Inc.
|
|
|
|
|
|
|
|
| SNTI / Senti Biosciences, Inc.
|
|
|
|
|
|
|
|
| SVRA / Savara Inc.
|
|
|
|
|
|
|
|
| ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| NN / NextNav Inc.
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CVRX / CVRx, Inc.
|
|
|
|
|
|
|
|
| ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CELC / Celcuity Inc.
|
|
|
|
|
|
|
|
| CSBR / Champions Oncology, Inc.
|
|
|
|
|
|
|
|
| BDTX / Black Diamond Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SRFM / Surf Air Mobility Inc.
|
|
|
|
|
|
|
|
| ZFOX / ZeroFox Holdings, Inc.
|
|
|
|
|
|
|
|
| XERS / Xeris Biopharma Holdings, Inc.
|
|
|
|
|
|
|
|
| ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| BZFD / BuzzFeed, Inc.
|
|
|
|
|
|
|
|
| UP / Wheels Up Experience Inc.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
| IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
| AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| MRKR / Marker Therapeutics, Inc.
|
|
|
|
|
|
|
|
| INZY / Inozyme Pharma, Inc.
|
|
|
|
|
|
|
|
| PHAT / Phathom Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
| KRRO / Korro Bio, Inc.
|
|
|
|
|
|
|
|
| TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NKTX / Nkarta, Inc.
|
|
|
|
|
|
|
|
| COUR / Coursera, Inc.
|
|
|
|
|
|
|
|
| SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
| ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
